Physician profile
Laura L Kuensting
NPI 1225247638
$9,056.13
in general payments reported to CMS, 2019-2025
39 companies · $1,781 in 2025
The $1,781 reported for 2025 was more than what 97% of Pediatrics (Registered Nurse) providers received nationally (typical 2025 total: $49.42).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,184 · 2022: $1,248 · 2023: $2,330 · 2024: $2,513 · 2025: $1,781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,623.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,283.61 | 2021-2025 | Fasenra, Farxiga |
| Amgen INC. | $839.74 | 2023-2025 | Repatha, Evenity |
| Abbvie INC. | $771.98 | 2022-2025 | |
| Glaxosmithkline, LLC. | $738.38 | 2021-2025 | Bexsero, Arexvy, Flulaval Quadrivalent |
| Supernus Pharmaceuticals, INC. | $492.22 | 2024-2025 | Qelbree |
| Tris Pharma INC | $424.08 | 2021-2025 | Dyanavel Xr, Quillivant, Quillichew Er |
| Pfizer INC. | $359.99 | 2022-2025 | |
| Ironshore Pharmaceuticals INC. | $331.86 | 2022-2024 | Jornay Pm |
| Abbott Laboratories | $296.97 | 2021-2025 | Freestyle Libre 3 |
| Kyowa Kirin, INC. | $291.98 | 2023-2024 | Crysvita, Nourianz |
| Corium, LLC | $280.67 | 2021-2023 | Azstarys |
| Neurelis, INC. | $254.17 | 2021-2025 | Valtoco |
| Edwards Lifesciences Corporation | $243.40 | 2022-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Axsome Therapeutics, INC. | $237.16 | 2024-2025 | Auvelity |
| Neurocrine Biosciences, INC. | $208.10 | 2022-2023 | Ingrezza |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Kuensting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.